glp-1 sarcopenia Glucagon-like peptide-1 receptor agonists and muscle mass effects GLP-1 Receptor Agonists for Obesity
Description
Over time, the medication helps to keep food intake at a manageable level, contributing to steady weight loss
Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance
GLP-1: glucagon-like peptide-1
Regular blood tests can help monitor and address any potential nutrient gaps, making it easier to adjust your diet as needed
Eligibility is typically a BMI of 30+, or 27+ with a weight-related condition, as determined by a licensed provider during your intake review
